VYNE Therapeutics
VYNE
VYNE
60 hedge funds and large institutions have $139M invested in VYNE Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 8 closing their positions.
Holders
60
Holders Change
+3
Holders Change %
+5.26%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
11
Increased
24
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
First Manhattan
New York
|
$17.7M |
2 |
O
2
OrbiMed
New York
|
$4.98M |
3 |
MP
3
Mangrove Partners
Greenwich,
Connecticut
|
$4.41M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$4.21M |
5 |
DM
5
Deerfield Management
New York
|
$1.56M |